Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reh-acteoside in IgA Nephropathy
NCT02662283Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- May 2016
- Primary completion
- Nov 2016
- Countries
- 1
01
Overview
A Phase 3 trial of acteoside in IgA nephropathy (IgAN), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
acteoside
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT02662283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02662283.